Physician profile
Patrick J Morello
NPI 1194760041
$1,780.50
in general payments reported to CMS, 2019-2025
9 companies · $92.70 in 2025
The $92.70 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,478 · 2020: $30.60 · 2021: $25.21 · 2022: $45.31 · 2023: $20.57 · 2024: $87.73 · 2025: $92.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,360.12 | 2019 | |
| Boston Scientific Corporation | $149.70 | 2020-2025 | General - Balloon Catheters, Resonate El Icd Vr |
| Abbott Laboratories | $81.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $53.82 | 2019 | |
| Abiomed | $39.34 | 2024 | |
| Amgen INC. | $36.14 | 2019 | |
| Shockwave Medical, INC | $20.57 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $20.49 | 2025 | |
| Ge Healthcare | $19.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Morello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.